OSAGE, Iowa–(BUSINESS WIRE)–Valent BioSciences LLC announced today that it has approved a major expansion of its biorational manufacturing facility in Osage, Iowa, which will meet increasing demand for its biorational products and the introduction of new products requiring more capacity. Construction will begin this summer and will be completed during the second quarter of 2024. … [Read more…]
VICTORVILLE, Calif.–(BUSINESS WIRE)–The Dr. Prem Reddy Family Foundation will present its largest scholarship award donation to 84 outstanding and diverse High Desert students seeking an education in the health sciences on Thursday, June 9 at 6 p.m., at Spring Valley Lake Country Club, 13229 Spring Valley Parkway in Victorville. From high school students overcoming significant … [Read more…]
Company completes analytical validation study evaluating performance of liquid biopsy test for pancreatic cancer SAN DIEGO–(BUSINESS WIRE)–Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy tests initially focused on non-invasive detection of high-mortality cancers in high-risk patient populations through a standard blood draw, today announced it has … [Read more…]
Enabling biomarker discovery and translation through increased sensitivity, throughput and robustness. FRAMINGHAM, Mass.–(BUSINESS WIRE)–#ASMS—SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches Zeno SWATH DIA, a significant step forward in biomarker discovery and translation workflows. Zeno SWATH DIA is the ultimate digital record of a sample that … [Read more…]
Features include Zeno SWATH DIA, stMRM, an integrated central console and accessibility across 9 languages FRAMINGHAM, Mass.–(BUSINESS WIRE)–#ASMS–At ASMS 2022, SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches SCIEX OS software v3.0, a software ecosystem built on accessibility, connectivity and integration. With this launch, SCIEX OS … [Read more…]
Developed exclusively by VieCure, it is designed to change the way the world treats cancer. DENVER–(BUSINESS WIRE)–VieCure, a cancer care company, announced today at ASCO 2022, the release of its next generation oncology clinical decision support platform including the introduction of Halo Intelligence for oncologists. The reality of cancer medicine today is the ever-increasing complexity … [Read more…]
PRINCE WILLIAM, Va.–(BUSINESS WIRE)–Capra Biosciences (Capra) today officially announced it has raised $1.8 million in an oversubscribed pre-seed funding round to advance their continuous-flow bioreactor technology, which changes the economics of making sustainable petrochemical replacements using biology. Capra will use the funding to build their production-scale reactor and extend its capabilities to include the production … [Read more…]
— Interim results of tisotumab vedotin plus pembrolizumab from Phase 1b/2 innovaTV 205 trial, showing 41% objective response rate in first-line patients with recurrent or metastatic cervical cancer (r/mCC), to be presented in an oral session — — Additional poster presentations to include debut of web-based tool for identifying geographical areas across the country in … [Read more…]
— Interim results of tisotumab vedotin plus pembrolizumab from Phase 1b/2 innovaTV 205 trial, showing 41% objective response rate in first-line patients with recurrent or metastatic cervical cancer (r/mCC), to be presented in an oral session — — Additional poster presentations to include debut of web-based tool for identifying geographical areas across the country in … [Read more…]
LOUISVILLE, Ky.–(BUSINESS WIRE)–Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Myovant Sciences to be a specialty pharmacy partner for ORGOVYX® (relugolix), which is a gonadotropin-releasing hormone (GnRH) antagonist that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with advanced prostate cancer. “Onco360 is honored … [Read more…]
